Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of the Anti-ADAMTS-5 Nanobody (R), M6495, in Healthy Male Subjects: A Phase I, Placebo-Controlled, First-in-Human Study
ARTHRITIS & RHEUMATOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要